Moral Distress: Its Manifestations in Healthy Donors during Peripheral Blood Hematopoietic Stem Cell Harvesting

•Moral distress can be observed in hematopoietic cell donors.•Anxiety was a frequent symptom observed in hematopoietic cell donors.•Physical symptoms, such as pain, may be present before starting the donation process. Hematopoietic stem cell donors (HSCDs) may have ambivalent feelings about donation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation and cellular therapy 2021-10, Vol.27 (10), p.853-858
Hauptverfasser: Gutiérrez-Aguirre, Cesar H., Jaime-Pérez, José C., de la Garza-Salazar, Fernando, Guerrero-González, Geraldina, Guzmán-López, Abel, Ruiz-Argüelles, Guillermo J., Gómez-Almaguer, David, Cantú-Rodríguez, Olga G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Moral distress can be observed in hematopoietic cell donors.•Anxiety was a frequent symptom observed in hematopoietic cell donors.•Physical symptoms, such as pain, may be present before starting the donation process. Hematopoietic stem cell donors (HSCDs) may have ambivalent feelings about donation. These feelings are related to moral obligation to help a sick relative and/or fear about the donation procedure. This ambivalence can produce moral distress (MD) and anxiety, which are usually unnoticed by the treating physician. The aim of this study was to evaluate the incidence of MD and anxiety in a group of related HSCDs for allogeneic transplantation. In this prospective observational study, to assess MD and anxiety, we applied 3 self-answered questionnaires—a questionnaire developed to assess MD (MDQ), State Trait Anxiety Index (STAI), and Edmonton Symptom Assessment System (ESAS)—before, during, and after hematopoietic stem cell donation. A total of 60 consecutive related HSCDs with a mean age of 38.2 years were included. Thirty-six were male. Hematopoietic stem cell collections were done by apheresis, performed as an outpatient process in all cases. The incidence of MD during the donation process was 56%. The proportion of HSCDs with moderate to high state anxiety decreased significantly from before donation (63%) to after donation (30%). Higher scores for MD correlated with higher scores on the STAI questionnaire (r = 0.448; P < .005). Thirty-seven donors (62%) had at least 1 physical symptom even before the stem cell mobilization process started, mainly anxiety (33%), difficulty sleeping (33%), and fatigue (30%). The number of symptomatic donors increased during donation (100%) and decreased after the procedure (80%). We conclude that MD and anxiety symptoms experienced by HSCDs are very common and can be explained by mixed feelings about the donation process. Providing comprehensive psychological support before starting the donation process and guaranteeing respect for the donor's autonomy are needed to decrease the negative impact of the donation experience.
ISSN:2666-6367
2666-6367
DOI:10.1016/j.jtct.2021.06.005